Font Size:
a
A
A
Keyword [immune-related adverse reactions]
Result: 1 - 3 | Page: 1 of 1
1.
Recent Advances In Tumor Immunotherapy Therapeutic Markers
2.
Clinical Study Of Carrelizumab Combined With First-line Chemotherapy For EGFR/ALK Mutation-negative Non Squamous Non-small-cell Lung Cancer
3.
Analysis Of The Efficacy And Safety Of Immune Checkpoint Inhibitors In The Treatment Of Advanced Non-small Cell Lung Cancer
<<First
<Prev Next>
Last>>
Jump to
